title: Adenosine conversion of supraventricular tachycardia associated with high-dose epinephrine therapy for cardiac arrest.
abstract: Adenosine has received wide acceptance as the drug of choice for initial treatment of supraventricular tachycardias (SVT), and as a diagnostic adjunct in hemodynamically stable, wide-complex tachycardias. This report describes the successful use of adenosine for the treatment of SVT occurring after successful initial resuscitation from ventricular fibrillation, in which a high dose of the epinephrine protocol was used.
authors.affiliation: Emergency Medical Service, William Beaumont Army Medical Center, El Paso, Texas 79920, USA.
authors.forename: R T
authors.initials: RT
authors.lastname: Gerhardt
authors.forename: R
authors.initials: R
authors.lastname: Furlong
authors.forename: K
authors.initials: K
authors.lastname: Schrank
authors.forename: B D
authors.initials: BD
authors.lastname: Ress
mesh_terms: D000241:Adenosine / Q000494:pharmacology / Q000627:therapeutic use*; D000368:Aged; D000369:Aged, 80 and over; D000889:Anti-Arrhythmia Agents / Q000494:pharmacology / Q000627:therapeutic use*; D016887:Cardiopulmonary Resuscitation / Q000009:adverse effects* / Q000379:methods*; D004554:Electric Countershock; D004562:Electrocardiography; D004632:Emergency Medical Services; D004837:Epinephrine / Q000009:adverse effects*; D006323:Heart Arrest / Q000188:drug therapy*; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D013617:Tachycardia, Supraventricular / Q000139:chemically induced* / Q000175:diagnosis / Q000188:drug therapy*; D014662:Vasoconstrictor Agents / Q000009:adverse effects*; D014693:Ventricular Fibrillation / Q000175:diagnosis / Q000188:drug therapy*
chemical_list: D000889:Anti-Arrhythmia Agents; D014662:Vasoconstrictor Agents; D000241:Adenosine; D004837:Epinephrine